Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F, et al. Le Chevalier T, et al. Among authors: douillard jy. Semin Oncol. 1994 Oct;21(5 Suppl 10):28-33; discussion 33-4. Semin Oncol. 1994. PMID: 7973766 Clinical Trial.
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, et al. Le Chevalier T, et al. Among authors: douillard jy. J Clin Oncol. 1994 Feb;12(2):360-7. doi: 10.1200/JCO.1994.12.2.360. J Clin Oncol. 1994. PMID: 8113844 Clinical Trial.
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Le Chevalier T, Brisgand D, Pujol JL, Douillard JY, Monnier A, Rivière A, Chomy P, Le Groumellec A, Ruffie P, Gottfried M, Gaspard MH, Chevreau C, Alberola V, Cigolari S, Besson F, Martinez A, Besenval M, Berthaud P, Tursz T. Le Chevalier T, et al. Among authors: douillard jy. Bull Cancer. 1996 May;83(5):385-94. Bull Cancer. 1996. PMID: 8680091 Clinical Trial. French.
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Pujol JL, Douillard JY, Rivière A, Quoix E, Lagrange JL, Berthaud P, Bardonnet-Comte M, Polin V, Gautier V, Milleron B, Chomy F, Chomy P, Spaeth D, Le Chevalier T. Pujol JL, et al. Among authors: douillard jy. J Clin Oncol. 1997 May;15(5):2082-9. doi: 10.1200/JCO.1997.15.5.2082. J Clin Oncol. 1997. PMID: 9164221 Clinical Trial.
A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
Bardet E, Rivière A, Charloux A, Spaeth D, Ducoloné A, Le Groumellec A, Pellae-Cosset B, Henry-Amar M, Douillard JY. Bardet E, et al. Among authors: douillard jy. Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):163-8. doi: 10.1016/s0360-3016(97)00254-x. Int J Radiat Oncol Biol Phys. 1997. PMID: 9212019 Clinical Trial.
331 results